Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific T cells may help treat alopecia areata.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Special cells can help regrow hair in alopecia areata.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

CDK4 levels affect the number of hair follicle stem cells in mice.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Treg cells help repair and regenerate tissues by interacting with local cells.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

CD133+ cells help heal diabetic ulcers by promoting blood vessel growth and activating Wnt signaling.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.